Market Overview:
The global pregnancy and ovulation testing market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of infertility, rising awareness about fertility tests, and technological advancements in the field of pregnancy and ovulation testing. The pregnancy testing segment is expected to account for the largest share of the global market in 2018. This segment is driven by factors such as rising incidence of early pregnancies, growing demand for home-based tests, and increasing use of advanced technologies such as point-of-care (POC) devices. The ovulation testing segment is projected to grow at a higher CAGR than the pregnancy testing segment during the forecast period. This growth can be attributed to factors such as growing awareness about fertility tests, increasing adoption rates for home-based ovulation tests, and technological advancements in this field.
Product Definition:
Pregnancy and ovulation testing is the process of using medical tests to determine whether a woman is pregnant or ovulating. The tests can be performed at home or in a doctor's office. Pregnancy testing is used to confirm pregnancy, while ovulation testing can help determine when a woman is most fertile.
Pregnancy Testing:
Pregnancy testing is used for determining the pregnancy status of women. It's primary function is to ensure that a fertilized egg has implanted in the uterus and it's also used for detecting any possible health issues pertaining to fetus development. Pregnancy testing kits are available in different forms such as home pregnancy tests, urine analyzers, blood tests and ultrasound scans among others.
Ovulation Testing:
Ovulation testing is a diagnostic test that helps in identifying the stage of ovulation. It also helps in determining the best time to have a baby for women who are planning to conceive. This test involves analyzing certain biomarkers present in urine, blood, or saliva sample of a woman. The presence or absence of these biomarkers can help determine if ovulation has taken place within 24 hours before collection of specimen for testing or not.
Application Insights:
Based on application, the global pregnancy and ovulation testing market is segmented into fertility centers, hospitals/clinics, others. The fertility centers held the largest share in 2017 due to increasing number of IVF procedures being performed there. Furthermore, these centers offer a high level of privacy and are equipped with state-of-the-art technology for diagnosing infertility.
The clinics segment is expected to grow at a faster rate than that of hospitals or other locations during the forecast period due to rising awareness about advanced assisted reproductive technologies (ART). In addition, this location offers more flexibility in scheduling appointments as compared to hospitals or other healthcare facilities. However, clinics require advanced equipment such as laparoscopes for performing diagnostic tests which may add costliness to an overall treatment plan.
Ovulation testing also has wide applications outside medical settings including private practices.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to rising awareness about early diagnosis of various disorders, increasing government initiatives, and high adoption of technologically advanced products. For instance, as per a research published by National Institute of Health (NIH), in 2015 around 2 million women between the age of 15 to 44 undergo pregnancy testing at least once a year. Furthermore, presence of major players such as Abbott Laboratories; American College Of Medical Genetics; Aviva Biosciences; BioDirection Corporation; CELGENE CORP.; and others is also contributing towards growth in this region.
Growth Factors:
- Increasing awareness about ovulation and pregnancy tests: There is a growing awareness among people about the use of ovulation and pregnancy tests. This is driving the growth of the market as more people are inclining towards using these tests for better understanding their reproductive health.
- Rising demand for home-based testing: A majority of consumers are preferring to do home-based testing for ovulation and pregnancy, which is aiding in the growth of this market. Home-based testing allows users to test themselves in privacy and comfort, without having to go through a healthcare professional.
- Technological advancements: The development of new technologies has led to innovative products being launched in the market, such as over-the-counter (OTC) digital devices that can help women track their fertility cycles easily and accurately. This is helping to drive demand for these products among consumers worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pregnancy and Ovulation Testing Market Research Report
By Type
Pregnancy Testing, Ovulation Testing
By Application
Fertility Centers, Hospitals, Clinics, Others
By Companies
SPD, Church & Dwight, BioMerieux, Alere, Rohto, Mankind Pharma, Geratherm Medical, Fairhaven Health, Quidel Corporation, Wondfo, Arax, Egens Biotech, RunBio, CIGA Healthcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Pregnancy and Ovulation Testing Market Report Segments:
The global Pregnancy and Ovulation Testing market is segmented on the basis of:
Types
Pregnancy Testing, Ovulation Testing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Fertility Centers, Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- SPD
- Church & Dwight
- BioMerieux
- Alere
- Rohto
- Mankind Pharma
- Geratherm Medical
- Fairhaven Health
- Quidel Corporation
- Wondfo
- Arax
- Egens Biotech
- RunBio
- CIGA Healthcare
Highlights of The Pregnancy and Ovulation Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pregnancy Testing
- Ovulation Testing
- By Application:
- Fertility Centers
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pregnancy and Ovulation Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pregnancy and ovulation testing is a way to determine if you are pregnant or have ovulated.
Some of the key players operating in the pregnancy and ovulation testing market are SPD, Church & Dwight, BioMerieux, Alere, Rohto, Mankind Pharma, Geratherm Medical, Fairhaven Health, Quidel Corporation, Wondfo, Arax, Egens Biotech, RunBio, CIGA Healthcare.
The pregnancy and ovulation testing market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pregnancy and Ovulation Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pregnancy and Ovulation Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pregnancy and Ovulation Testing Market - Supply Chain
4.5. Global Pregnancy and Ovulation Testing Market Forecast
4.5.1. Pregnancy and Ovulation Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pregnancy and Ovulation Testing Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pregnancy and Ovulation Testing Market Absolute $ Opportunity
5. Global Pregnancy and Ovulation Testing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pregnancy and Ovulation Testing Market Size and Volume Forecast by Type
5.3.1. Pregnancy Testing
5.3.2. Ovulation Testing
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pregnancy and Ovulation Testing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pregnancy and Ovulation Testing Market Size and Volume Forecast by Application
6.3.1. Fertility Centers
6.3.2. Hospitals
6.3.3. Clinics
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pregnancy and Ovulation Testing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pregnancy and Ovulation Testing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pregnancy and Ovulation Testing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pregnancy and Ovulation Testing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pregnancy and Ovulation Testing Demand Share Forecast, 2019-2026
9. North America Pregnancy and Ovulation Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pregnancy and Ovulation Testing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pregnancy and Ovulation Testing Market Size and Volume Forecast by Application
9.4.1. Fertility Centers
9.4.2. Hospitals
9.4.3. Clinics
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pregnancy and Ovulation Testing Market Size and Volume Forecast by Type
9.7.1. Pregnancy Testing
9.7.2. Ovulation Testing
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pregnancy and Ovulation Testing Demand Share Forecast, 2019-2026
10. Latin America Pregnancy and Ovulation Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pregnancy and Ovulation Testing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pregnancy and Ovulation Testing Market Size and Volume Forecast by Application
10.4.1. Fertility Centers
10.4.2. Hospitals
10.4.3. Clinics
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pregnancy and Ovulation Testing Market Size and Volume Forecast by Type
10.7.1. Pregnancy Testing
10.7.2. Ovulation Testing
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pregnancy and Ovulation Testing Demand Share Forecast, 2019-2026
11. Europe Pregnancy and Ovulation Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pregnancy and Ovulation Testing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pregnancy and Ovulation Testing Market Size and Volume Forecast by Application
11.4.1. Fertility Centers
11.4.2. Hospitals
11.4.3. Clinics
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pregnancy and Ovulation Testing Market Size and Volume Forecast by Type
11.7.1. Pregnancy Testing
11.7.2. Ovlation Testing
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pregnancy and Ovulation Testing Demand Share, 2019-2026
12. Asia Pacific Pregnancy and Ovulation Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pregnancy and Ovulation Testing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pregnancy and Ovulation Testing Market Size and Volume Forecast by Application
12.4.1. Fertility Centers
12.4.2. Hospitals
12.4.3. Clinics
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pregnancy and Ovulation Testing Market Size and Volume Forecast by Type
12.7.1. Pregnancy Testing
12.7.2. Ovulation Testing
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pregnancy and Ovulation Testing Demand Share, 2019-2026
13. Middle East & Africa Pregnancy and Ovulation Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pregnancy and Ovulation Testing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pregnancy and Ovulation Testing Market Size and Volume Forecast by Application
13.4.1. Fertility Centers
13.4.2. Hospitals
13.4.3. Clinics
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pregnancy and Ovulation Testing Market Size and Volume Forecast by Type
13.7.1. Pregnancy Testing
13.7.2. Ovulation Testing
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pregnancy and Ovulation Testing Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pregnancy and Ovulation Testing Market: Market Share Analysis
14.2. Pregnancy and Ovulation Testing Distributors and Customers
14.3. Pregnancy and Ovulation Testing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. SPD
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Church & Dwight
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. BioMerieux
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Alere
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Rohto
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Mankind Pharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Geratherm Medical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Fairhaven Health
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Quidel Corporation
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Wondfo
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Arax
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Egens Biotech
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. RunBio
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. CIGA Healthcare
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
